Pharma & Biotech Partnering Conference to Feature Deal Structures & Valuations on June 4-5 in Philadelphia

Apr 30, 2001, 01:00 ET from Strategic Research Institute

    PHILADELPHIA, April 30 /PRNewswire/ -- Presentation of important
 collaborative agreements that took place in 2000 and in early 2001 are the
 highlight of the "5th International Pharma & Biotech Licensing Deal-Making
 Summit" to take place in Philadelphia on June 4-5, 2001 announces, Strategic
 Research Institute.
     This may be the first conference to feature such a breadth of deal talks
 across such a gamut of therapeutic classes and enabling technologies.  This
 conference series is a major business development and networking extravaganza
 for the industry and biotech/biopharmaceutical investment community.
     A preliminary list of registered companies may be obtailed from Bebe
 Anderson at banderson@srinstitute.com
 
     Featured deals include:
 
     *  The Human Genome Sciences -- Cambridge Antibody Technologies
        Collaboration in Immunotherapy
     *  The Bayer AG -- CuraGen Alliance:  Landmark Drug Discovery, Development
        and Pharmcogenomic Partnership
     *  The Vertex -- Novartis Target Family Deal
     *  Elan Corporation: Spreading Risk Across Early-Stage Collaborations
        Through Structured Financing Arrangements
 
     Other deals are featured as well during the course of the conference.
 
     On the investment side, talks on prospective deals over the ensuing 12
 months and an analysis of biotech and genomic valuations are planned.  They
 are:
 
     Are Current Biotechnology & Genomic Valuations Justified?,
 by Mehta Partners LLC, and What Kinds of Deals Will We Likely See in Second
 Half 2001 -- First Half 2001, presented by Legg Mason Wood Walker.
 
     A reception and networking dinner are planned after the first day to
 foster interaction among speakers and attendees.
 
     To register/request the agenda, please contact Sem Sepulveda at
 ssepulveda@srinstitute.com, Sumeet Hora at shora@srinstitute.com or
 212-967-0095, extension 261.  Contact Mark Alexay for information on
 exhibiting or sponsoring a function at malexay@srinstitute.com
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X84869548
 
 

SOURCE Strategic Research Institute
    PHILADELPHIA, April 30 /PRNewswire/ -- Presentation of important
 collaborative agreements that took place in 2000 and in early 2001 are the
 highlight of the "5th International Pharma & Biotech Licensing Deal-Making
 Summit" to take place in Philadelphia on June 4-5, 2001 announces, Strategic
 Research Institute.
     This may be the first conference to feature such a breadth of deal talks
 across such a gamut of therapeutic classes and enabling technologies.  This
 conference series is a major business development and networking extravaganza
 for the industry and biotech/biopharmaceutical investment community.
     A preliminary list of registered companies may be obtailed from Bebe
 Anderson at banderson@srinstitute.com
 
     Featured deals include:
 
     *  The Human Genome Sciences -- Cambridge Antibody Technologies
        Collaboration in Immunotherapy
     *  The Bayer AG -- CuraGen Alliance:  Landmark Drug Discovery, Development
        and Pharmcogenomic Partnership
     *  The Vertex -- Novartis Target Family Deal
     *  Elan Corporation: Spreading Risk Across Early-Stage Collaborations
        Through Structured Financing Arrangements
 
     Other deals are featured as well during the course of the conference.
 
     On the investment side, talks on prospective deals over the ensuing 12
 months and an analysis of biotech and genomic valuations are planned.  They
 are:
 
     Are Current Biotechnology & Genomic Valuations Justified?,
 by Mehta Partners LLC, and What Kinds of Deals Will We Likely See in Second
 Half 2001 -- First Half 2001, presented by Legg Mason Wood Walker.
 
     A reception and networking dinner are planned after the first day to
 foster interaction among speakers and attendees.
 
     To register/request the agenda, please contact Sem Sepulveda at
 ssepulveda@srinstitute.com, Sumeet Hora at shora@srinstitute.com or
 212-967-0095, extension 261.  Contact Mark Alexay for information on
 exhibiting or sponsoring a function at malexay@srinstitute.com
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X84869548
 
 SOURCE  Strategic Research Institute